{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:43:43Z","timestamp":1787024623804,"version":"build-2736575974"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Emerging lipid-based carriers are revolutionizing drug delivery in the pharmaceutical and biomedical\nsciences. These innovative carriers harness the unique properties of lipids to improve the solubility,\nstability, and targeted delivery of therapeutic agents, ushering in a new era of precision medicine. Lipid-\nbased carriers, such as liposomes, lipid nanoparticles, and solid lipid nanoparticles, offer several advantages.\nThey can encapsulate both hydrophilic and hydrophobic drugs, enabling the delivery of a wide\nrange of compounds. Additionally, lipids are biocompatible and biodegradable, minimizing the risk of\ntoxicity. Their ability to mimic cell membranes allows for enhanced cellular uptake and controlled release,\noptimizing drug efficacy while minimizing side effects. Furthermore, lipid-based carriers are ideal\nfor delivering drugs to specific sites within the body. By modifying the lipid composition, surface charge,\nand size, researchers can tailor these carriers to target tumours, inflamed tissues, or specific cells, improving\ntherapeutic outcomes and reducing systemic toxicity. In summary, emerging lipid-based carriers are\npoised to transform pharmaceutical and biomedical sciences by addressing critical challenges in drug\ndelivery. These carriers enhance drug stability, bioavailability, and targeted delivery, offering the potential\nto revolutionize the treatment of various diseases and improve patient outcomes. As research in this\nfield continues to advance, we can expect even more sophisticated lipid-based carrier systems to emerge,\nfurther expanding the possibilities for precision medicine. This review focuses on the contribution of lipid\ncarriers in the pharmaceutical and biomedical sciences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0122117385268268231204061938","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T05:16:43Z","timestamp":1706505403000},"page":"2-21","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Emerging Lipid-based Carriers for Systematic Utilization in the Pharmaceutical and Biomedical Sciences: A Review"],"prefix":"10.2174","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2218-2226","authenticated-orcid":true,"given":"Prakash N.","family":"Kendre","sequence":"first","affiliation":[{"name":"Rajarshi Shahu College of Pharmacy, Buldhana, 443001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj R.","family":"Kayande","sequence":"additional","affiliation":[{"name":"Rajarshi Shahu College of Pharmacy, Buldhana, 443001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajinkya K.","family":"Pote","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Rajarshi\nShahu College of Pharmacy, Khamgaon-Botha Road, Malvihir, Buldhana, 443001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanagmeshwar B.","family":"Kanthale","sequence":"additional","affiliation":[{"name":"Rajarshi Shahu College of Pharmacy, Buldhana, 443001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra G.","family":"Prajapati","sequence":"additional","affiliation":[{"name":"S. K. Patel College of\nPharmaceutical Education and Research, Ganpat University, Ganpat Vidya Nagar, Mehsana, 384012, Gujrat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuvraj","family":"Kendre","sequence":"additional","affiliation":[{"name":"Podar International School, Buldhana, 443001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Jain","sequence":"additional","affiliation":[{"name":"Rajarshi Shahu College of Pharmacy, Buldhana, 443001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejpb.2011.01.021","volume":"79","author":"Roger E.","year":"2011","unstructured":"Roger E.; Lagarce F.; Benoit J.P.; Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur J Pharm Biopharm  2011,79(1),181-188","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijpharm.2005.05.032","volume":"301","author":"Prabhu S.","year":"2005","unstructured":"Prabhu S.; Ortega M.; Ma C.; Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int J Pharm  2005,301(1-2),209-216","journal-title":"Int J Pharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"Amidon G.L.","year":"1995","unstructured":"Amidon G.L.; Lennern\u00e4s H.; Shah V.P.; Crison J.R.; A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res  1995,12(3),413-420","journal-title":"Pharm Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1016\/S0169-409X(01)00182-X","volume":"50","author":"Porter C.J.H.","year":"2001","unstructured":"Porter C.J.H.; Charman W.N.; In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev  2001,50(Suppl. 1),S127-S147","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0169-409X(02)00044-3","volume":"54","author":"Brigger I.","year":"2002","unstructured":"Brigger I.; Dubernet C.; Couvreur P.; Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev  2002,54(5),631-651","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","volume":"55","author":"Panyam J.","year":"2003","unstructured":"Panyam J.; Labhasetwar V.; Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev  2003,55(3),329-347","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"M\u00fcller R.H.","year":"2002","unstructured":"M\u00fcller R.H.; Radtke M.; Wissing S.A.; Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev  2002,54(Suppl. 1),S131-S155","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.3109\/9781420017267","author":"Hauss DJ","year":"2007","unstructured":"Hauss DJ;  Oral lipid-based formulations\u202f: Enhancing the bioavailability of poorly water-soluable drugs  2007","journal-title":"Oral lipid-based formulations\u202f: Enhancing the bioavailability of poorly water-soluable drugs"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","volume":"73","author":"Chakraborty S.","year":"2009","unstructured":"Chakraborty S.; Shukla D.; Mishra B.; Singh S.; Lipid - An emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm  2009,73(1),1-15","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"Pouton C.W.","year":"2000","unstructured":"Pouton C.W.; Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems. Eur J Pharm Sci  2000,11(Suppl. 2),S93-S98","journal-title":"Eur J Pharm Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","volume":"60","author":"Porter C.J.H.","year":"2008","unstructured":"Porter C.J.H.; Pouton C.W.; Cuine J.F.; Charman W.N.; Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev  2008,60(6),673-691","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/9781420017267-4","author":"Strickley R.G.","year":"2007","unstructured":"Strickley R.G.; Currently marketed oral lipid-based dosage forms: Drug products and excipients. Oral Lipid-Based Formulat  2007,23-54","journal-title":"Oral Lipid-Based Formulat"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","volume":"420","author":"Kawabata Y.","year":"2011","unstructured":"Kawabata Y.; Wada K.; Nakatani M.; Yamada S.; Onoue S.; Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm  2011,420(1),1-10","journal-title":"Int J Pharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ejpb.2009.03.001","volume":"72","author":"Balakrishnan P.","year":"2009","unstructured":"Balakrishnan P.; Lee B.J.; Oh D.H.; Kim J.O.; Hong M.J.; Jee J.P.; Kim J.A.; Yoo B.K.; Woo J.S.; Yong C.S.; Choi H.G.; Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm  2009,72(3),539-545","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s11095-013-1107-3","volume":"30","author":"Tan A.","year":"2013","unstructured":"Tan A.; Rao S.; Prestidge C.A.; Transforming lipid-based oral drug delivery systems into solid dosage forms: An overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm Res  2013,30(12),2993-3017","journal-title":"Pharm Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","volume":"60","author":"Pouton C.W.","year":"2008","unstructured":"Pouton C.W.; Porter C.J.H.; Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev  2008,60(6),625-637","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5507\/bp.2001.008","volume":"145","author":"Stuchl\u00edk M.","year":"2001","unstructured":"Stuchl\u00edk M.; \u017d\u00e1k S.; Lipid-based vehicle for oral drug delivery. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub  2001,145(2),17-26","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=18","first-page":"918","author":"Rowe R.C.","year":"2006","unstructured":"Rowe R.C.; Sheskey P.J.; Owen S.C.;  Handbook of pharmaceutical excipients  2006,918","journal-title":"Handbook of pharmaceutical excipients"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/BFB0118612\/COVER","volume":"93","author":"Westesen K.","year":"1993","unstructured":"Westesen K.; Siekmann B.; Koch M.H.J.; Characterization of submicron-sized drug carrier systems based on solid lipids by synchrotron radiation x-ray diffraction. Prog Colloid Polym Sci  1993,93,356","journal-title":"Prog Colloid Polym Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/801820","volume":"2014","author":"Shrestha H.","year":"2014","unstructured":"Shrestha H.; Bala R.; Arora S.; Lipid-based drug delivery systems. J Pharm  2014,2014,1-10","journal-title":"J Pharm"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","volume":"3","author":"Kalepu S.","year":"2013","unstructured":"Kalepu S.; Manthina M.; Padavala V.; Oral lipid-based drug delivery systems - An overview. Acta Pharm Sin B  2013,3(6),361-372","journal-title":"Acta Pharm Sin B"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.9734\/jalsi\/2021\/v24i330228","author":"Zubair A-HA","year":"2021","unstructured":"Zubair A-HA; Sheshe SM; Bashir MR; Sade SM; Lipid based drug delivery system: A review. J Appl Life Sci Int  2021,33-46","journal-title":"J Appl Life Sci Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"Paliwal R.","year":"2020","unstructured":"Paliwal R.; Paliwal S.R.; Kenwat R.; Kurmi B.D.; Sahu M.K.; Solid lipid nanoparticles: A review on recent perspectives and patents. Expert Opin Ther Pat  2020,30(3),179-194","journal-title":"Expert Opin Ther Pat"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijpharm.2005.08.018","volume":"304","author":"Attama A.A.","year":"2005","unstructured":"Attama A.A.; Nkemnele M.O.; In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm  2005,304(1-2),4-10","journal-title":"Int J Pharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","volume":"30","author":"Schwarz C.","year":"1994","unstructured":"Schwarz C.; Mehnert W.; Lucks J.S.; M\u00fcller R.H.; Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release  1994,30(1),83-96","journal-title":"J Control Release"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0939-6411(01)00233-8","volume":"53","author":"Lippacher A.","year":"2002","unstructured":"Lippacher A.; M\u00fcller R.H.; M\u00e4der K.; Semisolid SLN\u2122 dispersions for topical application: Influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm  2002,53(2),155-160","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","volume":"51","author":"Salvi V.R.","year":"2019","unstructured":"Salvi V.R.; Pawar P.; Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. J Drug Deliv Sci Technol  2019,51,255-267","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/1061186021000001832","volume":"10","author":"Olbrich C.","year":"2002","unstructured":"Olbrich C.; Gessner A.; Kayser O.; M\u00fcller R.H.; Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J Drug Target  2002,10(5),387-396","journal-title":"J Drug Target"},{"key":"ref=29","first-page":"25","volume":"10","author":"Onuigbo E.B.","year":"2011","unstructured":"Onuigbo E.B.; Okore V.C.; Ngene A.A.; Esimone C.O.; Attama A.A.; Preliminary studies of a stearylamine-based cationic liposome. J Pharm Res  2011,10,25-29","journal-title":"J Pharm Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/03079457.2012.691154","volume":"41","author":"Onuigbo E.B.","year":"2012","unstructured":"Onuigbo E.B.; Okore V.C.; Ofokansi K.C.; Okoye J.O.A.; Nworu C.S.; Esimone C.O.; Attama A.A.; Preliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposome. Avian Pathol  2012,41(4),355-360","journal-title":"Avian Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.drudis.2010.09.006","volume":"15","author":"Guo C.","year":"2010","unstructured":"Guo C.; Wang J.; Cao F.; Lee R.J.; Zhai G.; Lyotropic liquid crystal systems in drug delivery. Drug Discov Today  2010,15(23-24),1032-1040","journal-title":"Drug Discov Today"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","volume":"172","author":"Uchegbu I.F.","year":"1998","unstructured":"Uchegbu I.F.; Vyas S.P.; Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm  1998,172(1-2),33-70","journal-title":"Int J Pharm"},{"key":"ref=33","first-page":"182","author":"Conacher M","year":"2000","unstructured":"Conacher M; Alexander J; Brewer JM; Niosomes as immunological adjuvants.  2000,182-205"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/0378-6323.32709","volume":"73","author":"Lakshmi P.K.","year":"2007","unstructured":"Lakshmi P.K.; Devi G.; Bhaskaran S.; Sacchidanand S.; Niosomal methotrexate gel in the treatment of localized psoriasis: Phase I and phase II studies. Indian J Dermatol Venereol Leprol  2007,73(3),157-161","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0005-2736(97)00177-6","volume":"1368","author":"Cevc G.","year":"1998","unstructured":"Cevc G.; Gebauer D.; Stieber J.; Sch\u00e4tzlein A.; Blume G.; Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta Biomembr  1998,1368(2),201-215","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0005-2736(02)00401-7","volume":"1564","author":"Cevc G.","year":"2002","unstructured":"Cevc G.; Sch\u00e4tzlein A.; Richardsen H.; Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta Biomembr  2002,1564(1),21-30","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4236\/jbnb.2011.225075","volume":"2","author":"Lovelyn C.","year":"2011","unstructured":"Lovelyn C.; Attama A.A.; Lovelyn C.; Attama A.A.; Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol  2011,2(5),626-639","journal-title":"J Biomater Nanobiotechnol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1517\/17425247.2012.668523","volume":"9","author":"Kotta S.","year":"2012","unstructured":"Kotta S.; Khan A.W.; Pramod K.; Ansari S.H.; Sharma R.K.; Ali J.; Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv  2012,9(5),585-598","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=39","author":"Cannon J.B.","year":"2008","unstructured":"Cannon J.B.; Long M.A.; Emulsions, microemulsions, and lipid-based drug delivery systems for drug solubilization and delivery, Part II: Oral applications.  2008"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1023\/A:1016268311867","volume":"12","author":"Constantinides P.P.","year":"1995","unstructured":"Constantinides P.P.; Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res  1995,12(11),1561-1572","journal-title":"Pharm Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","volume":"21","author":"Strickley R.G.","year":"2004","unstructured":"Strickley R.G.; Solubilizing excipients in oral and injectable formulations. Pharm Res  2004,21(2),201-230","journal-title":"Pharm Res"},{"key":"ref=42","first-page":"132","volume":"10","author":"Cannon B.","year":"2007","unstructured":"Cannon B.; Chemical and physical stability considerations for lipid-based drug formulations. Am Pharm Rev  2007,10,132-138","journal-title":"Am Pharm Rev"},{"key":"ref=43","author":"Christie WW","year":"1987","unstructured":"Christie WW;  High-performance liquid chromatography and lipids: A practical guide  1987","journal-title":"High-performance liquid chromatography and lipids: A practical guide"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"103A","DOI":"10.1002\/bbpc.198800024","volume":"92","author":"Rehage H.","year":"1988","unstructured":"Rehage H.; M. J. Schick (Ed.): Nonionic Surfactants: Physical Chemistry, Vol. 23 aus: Surfactant Science Series, Marcel Dekker Inc., New York 1987. 1160 Seiten, Preis: $ 195.00 (U.S. und Canada), $ 234.00 (alle anderen L\u00e4nder). Ber Bunsenges Phys Chem  1988,92(1),103A-104","journal-title":"Ber Bunsenges Phys Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","volume":"25","author":"Pouton C.W.","year":"1997","unstructured":"Pouton C.W.; Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev  1997,25(1),47-58","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1002\/jps.20126","volume":"93","author":"Cao Y.","year":"2004","unstructured":"Cao Y.; Marra M.; Anderson B.D.; Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. J Pharm Sci  2004,93(11),2768-2779","journal-title":"J Pharm Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/B:PHAM.0000016282.77887.1f","volume":"21","author":"Kaukonen A.M.","year":"2004","unstructured":"Kaukonen A.M.; Boyd B.J.; Porter C.J.H.; Charman W.N.; Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res  2004,21(2),245-253","journal-title":"Pharm Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","volume":"111","author":"Collnot E.M.","year":"2006","unstructured":"Collnot E.M.; Baldes C.; Wempe M.F.; Hyatt J.; Navarro L.; Edgar K.J.; Schaefer U.F.; Lehr C.M.; Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release  2006,111(1-2),35-40","journal-title":"J Control Release"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jconrel.2020.05.049","volume":"324","author":"Li X.","year":"2020","unstructured":"Li X.; Yang L.; Chen X.; Shi S.; Green synthesis of silver nanoparticles incorporated in lipid nanocarriers for improving stability and drug-loading capacity. J Control Release  2020,324,471-482","journal-title":"J Control Release"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/S0142-9612(01)00362-3","volume":"23","author":"Cortesi R.","year":"2002","unstructured":"Cortesi R.; Esposjto E.; Luca G.; Nastruzzi C.; Production of lipospheres as carriers for bioactive compounds. Biomaterials  2002,23(11),2283-2294","journal-title":"Biomaterials"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.apt.2021.03.028","volume":"32","author":"Sorita G.D.","year":"2021","unstructured":"Sorita G.D.; Santamaria-Echart A.; Gozzo A.M.; Gon\u00e7alves O.H.; Leimann F.V.; Bona E.; Manrique Y.; Fernandes I.P.M.; Ferreira I.C.F.R.; Barreiro M.F.; Lipid composition optimization in spray congealing technique and testing with curcumin-loaded microparticles. Adv Powder Technol  2021,32(5),1710-1722","journal-title":"Adv Powder Technol"},{"key":"ref=52a","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jconrel.2020.05.049","unstructured":"Li, X., Yang, L., Chen, X., and Shi, S. (2020) Green synthesis of silver nanoparticles incorporated in lipid nanocarriers for improving stability and drug-loading capacity. Journal of Controlled Release, 324  ,471-482","journal-title":"Journal of Controlled Release, 324"},{"key":"ref=52b","doi-asserted-by":"publisher","first-page":"118784","DOI":"10.1016\/j.ijpharm.2019.118784","volume":"572","author":"Sanchez-Vazquez B.","year":"2019","unstructured":"Sanchez-Vazquez B.; Lee J.B.; Strimaite M.; Buanz A.; Bailey R.; Gershkovich P.; Pasparakis G.; Williams G.R.; Solid lipid nanoparticles self-assembled from spray dried microparticles. Int J Pharm  2019,572,118784","journal-title":"Int J Pharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijpharm.2005.11.014","volume":"310","author":"Venkatesan N.","year":"2006","unstructured":"Venkatesan N.; Yoshimitsu J.; Ohashi Y.; Ito Y.; Sugioka N.; Shibata N.; Takada K.; Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs. Int J Pharm  2006,310(1-2),46-52","journal-title":"Int J Pharm"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2005.03.017","volume":"105","author":"Ito Y.","year":"2005","unstructured":"Ito Y.; Kusawake T.; Ishida M.; Tawa R.; Shibata N.; Takada K.; Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release  2005,105(1-2),23-31","journal-title":"J Control Release"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jddst.2017.04.024","volume":"39","author":"Krstic M.","year":"2017","unstructured":"Krstic M.; Djuris J.; Petrovic O.; Lazarevic N.; Cvijic S.; Ibric S.; Application of the melt granulation technique in development of lipid matrix tablets with immediate release of carbamazepine. J Drug Deliv Sci Technol  2017,39,467-474","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/1556-276X-8-386","volume":"8","author":"Santo I.E.","year":"2013","unstructured":"Santo I.E.; Pedro A.S.; Fialho R.; Cabral-Albuquerque E.; Characteristics of lipid micro- and nanoparticles based on supercritical formation for potential pharmaceutical application. Nanoscale Res Lett  2013,8(1),386","journal-title":"Nanoscale Res Lett"},{"key":"ref=57a","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.JCONREL.2005.03.017","volume":"105","author":"Ito Y","year":"2005","unstructured":"Ito Y; Kusawake T; Ishida M; Tawa R; Shibata N; Takada K; Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release  2005,105,23-31","journal-title":"J Control Release"},{"key":"ref=57b","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/187221111797200524","volume":"5","author":"Attama A.A.","year":"2011","unstructured":"Attama A.A.; SLN, NLC, LDC: State of the art in drug and active delivery. Recent Pat Drug Deliv Formul  2011,5(3),178-187","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","volume":"48","author":"Westesen K.","year":"1997","unstructured":"Westesen K.; Bunjes H.; Koch M.H.J.; Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release  1997,48(2-3),223-236","journal-title":"J Control Release"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/03639040500216428","volume":"31","author":"Wei L.","year":"2005","unstructured":"Wei L.; Sun P.; Nie S.; Pan W.; Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm  2005,31(8),785-794","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0169-409X(01)00148-X","volume":"50","author":"Edwards G.","year":"2001","unstructured":"Edwards G.; Porter C.J.; Caliph S.M.; Charman W.N.; Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev  2001,50(1-2),45-60","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1023\/A:1024422625596","volume":"20","author":"Seeballuck F.","year":"2003","unstructured":"Seeballuck F.; Ashford M.B.; O\u2019Driscoll C.M.; The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm Res  2003,20(7),1085-1092","journal-title":"Pharm Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/pharmaceutics12111065","volume":"12","author":"Khattak M.I.K.","year":"2020","unstructured":"Khattak M.I.K.; Ahmed N.; Umer M.F.; Riaz A.; Ahmad N.M.; Khan G.M.; Chloroform-Injection (CI) and Spontaneous-Phase-Transition (SPT) are novel methods, simplifying the fabrication of liposomes with versatile solution to cholesterol content and size distribution. Pharmaceutics  2020,12(11),1065","journal-title":"Pharmaceutics"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"119566","DOI":"10.1016\/j.ijpharm.2020.119566","volume":"586","author":"Roces C.B.","year":"2020","unstructured":"Roces C.B.; Port E.C.; Daskalakis N.N.; Watts J.A.; Aylott J.W.; Halbert G.W.; Perrie Y.; Rapid scale-up and production of active-loaded PEGylated liposomes. Int J Pharm  2020,586,119566","journal-title":"Int J Pharm"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/pharmaceutics12111001","volume":"12","author":"Yanar F.","year":"2020","unstructured":"Yanar F.; Mosayyebi A.; Nastruzzi C.; Carugo D.; Zhang X.; Continuous-flow production of liposomes with a millireactor under varying fluidic conditions. Pharmaceutics  2020,12(11),1001","journal-title":"Pharmaceutics"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.2147\/IJN.S157375","volume":"13","author":"Ogawa K.","year":"2018","unstructured":"Ogawa K.; Fuchigami Y.; Hagimori M.; Fumoto S.; Miura Y.; Kawakami S.; Efficient gene transfection to the brain with ultrasound irradiation in mice using stabilized bubble lipopolyplexes prepared by the surface charge regulation method. Int J Nanomedicine  2018,13,2309-2320","journal-title":"Int J Nanomedicine"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2019.03.021","volume":"302","author":"Peng J.Q.","year":"2019","unstructured":"Peng J.Q.; Fumoto S.; Suga T.; Miyamoto H.; Kuroda N.; Kawakami S.; Nishida K.; Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles. J Control Release  2019,302,42-53","journal-title":"J Control Release"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1910575","DOI":"10.1002\/adfm.201910575","volume":"30","author":"Tanaka H.","year":"2020","unstructured":"Tanaka H.; Takahashi T.; Konishi M.; Takata N.; Gomi M.; Shirane D.; Miyama R.; Hagiwara S.; Yamasaki Y.; Sakurai Y.; Ueda K.; Higashi K.; Moribe K.; Shinsho E.; Nishida R.; Fukuzawa K.; Yonemochi E.; Okuwaki K.; Mochizuki Y.; Nakai Y.; Tange K.; Yoshioka H.; Tamagawa S.; Akita H.; Self\u2010degradable lipid\u2010like materials based on \u201chydrolysis accelerated by the intra\u2010particle enrichment of reactant (HyPER)\u201d for messenger RNA delivery. Adv Funct Mater  2020,30(34),1910575","journal-title":"Adv Funct Mater"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/pharmaceutics12060589","volume":"12","author":"Garcia-Pinel B.","year":"2020","unstructured":"Garcia-Pinel B.; Jabalera Y.; Ortiz R.; Cabeza L.; Jimenez-Lopez C.; Melguizo C.; Prados J.; Biomimetic magnetoliposomes as oxaliplatin nanocarriers: In vitro study for potential application in colon cancer. Pharmaceutics  2020,12(6),589","journal-title":"Pharmaceutics"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/pharmaceutics12111022","volume":"12","author":"Lara P.","year":"2020","unstructured":"Lara P.; Chan A.B.; Cruz L.J.; Quest A.F.G.; Kogan M.J.; Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues. Pharmaceutics  2020,12(11),1022","journal-title":"Pharmaceutics"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/pharmaceutics12090897","volume":"12","author":"Ledezma-Gallegos F.","year":"2020","unstructured":"Ledezma-Gallegos F.; Jurado R.; Mir R.; Medina L.A.; Mondragon-Fuentes L.; Garcia-Lopez P.; Liposomes co-encapsulating cisplatin\/mifepristone improve the effect on cervical cancer: In vitro and in vivo assessment. Pharmaceutics  2020,12(9),897","journal-title":"Pharmaceutics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/pharmaceutics12111070","volume":"12","author":"Fumoto S","year":"2020","unstructured":"Fumoto S; Kinoshita E; Ohta K; Nakamura KI; Hirayama T; Nagasawa H; A pH-adjustable tissue clearing solution that preserves lipid ultrastructures: Suitable tissue clearing method for DDS evaluation. Pharmaceutics  2020,12,1070","journal-title":"Pharmaceutics"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"E199","DOI":"10.36076\/ppj.2013\/16\/E199","volume":"3","author":"Hua S.","year":"2013","unstructured":"Hua S.; Cabot P.J.; Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: A potential novel treatment of acute and chronic pain condition. Pain Physician  2013,3(16),E199-E216","journal-title":"Pain Physician"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"20140459","DOI":"10.1098\/rsif.2014.0459","volume":"11","author":"Monteiro N.","year":"2014","unstructured":"Monteiro N.; Martins A.; Reis R.L.; Neves N.M.; Liposomes in tissue engineering and regenerative medicine. J R Soc Interface  2014,11(101),20140459","journal-title":"J R Soc Interface"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","volume":"26","author":"Puri A.","year":"2009","unstructured":"Puri A.; Loomis K.; Smith B.; Lee J.H.; Yavlovich A.; Heldman E.; Blumenthal R.; Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic. Crit Rev Ther Drug Carrier Syst  2009,26(6),523-580","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(97)00128-2","volume":"32","author":"Semple S.C.","year":"1998","unstructured":"Semple S.C.; Chonn A.; Cullis P.R.; Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv Drug Deliv Rev  1998,32(1-2),3-17","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"Bozzuto G.","year":"2015","unstructured":"Bozzuto G.; Molinari A.; Liposomes as nanomedical devices. Int J Nanomedicine  2015,10,975-999","journal-title":"Int J Nanomedicine"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/immu.1994.1027","volume":"4","author":"Torchilin V.P.","year":"1994","unstructured":"Torchilin V.P.; Immunoliposomes and PEGylated immunoliposomes: Possible use for targeted delivery of imaging agents. ImmunoMethods  1994,4(3),244-258","journal-title":"ImmunoMethods"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/immu.1994.1028","volume":"4","author":"Vingerhoeds M.H.","year":"1994","unstructured":"Vingerhoeds M.H.; Storm G.; Crommelin D.J.A.; Immunoliposomes in vivo. ImmunoMethods  1994,4(3),259-272","journal-title":"ImmunoMethods"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0169-409X(97)00083-5","volume":"29","author":"Forssen E.","year":"1998","unstructured":"Forssen E.; Willis M.; Ligand-targeted liposomes. Adv Drug Deliv Rev  1998,29(3),249-271","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cbpa.2005.06.001","volume":"9","author":"Ferrari M.","year":"2005","unstructured":"Ferrari M.; Nanovector therapeutics. Curr Opin Chem Biol  2005,9(4),343-346","journal-title":"Curr Opin Chem Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/anie.200802585","volume":"48","author":"Riehemann K.","year":"2009","unstructured":"Riehemann K.; Schneider S.W.; Luger T.A.; Godin B.; Ferrari M.; Fuchs H.; Nanomedicine--challenge and perspectives. Angew Chem Int Ed  2009,48(5),872-897","journal-title":"Angew Chem Int Ed"},{"key":"ref=82","first-page":"6551","volume":"9","author":"Gabizon A.","year":"2003","unstructured":"Gabizon A.; Horowitz A.T.; Goren D.; Tzemach D.; Shmeeda H.; Zalipsky S.; In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res  2003,9(17),6551-6559","journal-title":"Clin Cancer Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","volume":"66","author":"Kirpotin D.B.","year":"2006","unstructured":"Kirpotin D.B.; Drummond D.C.; Shao Y.; Shalaby M.R.; Hong K.; Nielsen U.B.; Marks J.D.; Benz C.C.; Park J.W.; Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res  2006,66(13),6732-6740","journal-title":"Cancer Res"},{"key":"ref=84","first-page":"1172","volume":"8","author":"Park J.W.","year":"2002","unstructured":"Park J.W.; Hong K.; Kirpotin D.B.; Colbern G.; Shalaby R.; Baselga J.; Shao Y.; Nielsen U.B.; Marks J.D.; Moore D.; Papahadjopoulos D.; Benz C.C.; Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery. Clin Cancer Res  2002,8(4),1172-1181","journal-title":"Clin Cancer Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1208\/s12248-012-9330-0","volume":"14","author":"Sawant R.R.","year":"2012","unstructured":"Sawant R.R.; Torchilin V.P.; Challenges in development of targeted liposomal therapeutics. AAPS J  2012,14(2),303-315","journal-title":"AAPS J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jps.23773","volume":"103","author":"Kraft J.C.","year":"2014","unstructured":"Kraft J.C.; Freeling J.P.; Wang Z.; Ho R.J.Y.; Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci  2014,103(1),29-52","journal-title":"J Pharm Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","volume":"11","author":"Hua S.","year":"2015","unstructured":"Hua S.; Marks E.; Schneider J.J.; Keely S.; Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue. Nanomedicine  2015,11(5),1117-1132","journal-title":"Nanomedicine"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.07.017","volume":"440","author":"Coco R.","year":"2013","unstructured":"Coco R.; Plapied L.; Pourcelle V.; J\u00e9r\u00f4me C.; Brayden D.J.; Schneider Y.J.; Pr\u00e9at V.; Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies. Int J Pharm  2013,440(1),3-12","journal-title":"Int J Pharm"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/glycob\/cwp048","volume":"19","author":"Holm\u00e9n Larsson J.M.","year":"2009","unstructured":"Holm\u00e9n Larsson J.M.; Karlsson H.; Sj\u00f6vall H.; Hansson G.C.; A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC\/MSn. Glycobiology  2009,19(7),756-766","journal-title":"Glycobiology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","volume":"20","author":"Antoni L.","year":"2014","unstructured":"Antoni L.; Nuding S.; Wehkamp J.; Stange E.F.; Intestinal barrier in inflammatory bowel disease. World J Gastroenterol  2014,20(5),1165-1179","journal-title":"World J Gastroenterol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/j.1572-0241.1999.01223.x","volume":"94","author":"Carlson M.","year":"1999","unstructured":"Carlson M.; Raab Y.; Peterson C.; H\u00e4llgren R.; Venge P.; Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol  1999,94(7),1876-1883","journal-title":"Am J Gastroenterol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1572-0241.2002.05837.x","volume":"97","author":"Peterson C.G.B.","year":"2002","unstructured":"Peterson C.G.B.; Eklund E.; Taha Y.; Raab Y.; Carlson M.; A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: Establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol  2002,97(7),1755-1762","journal-title":"Am J Gastroenterol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"Felgner P.L.","year":"1987","unstructured":"Felgner P.L.; Gadek T.R.; Holm M.; Roman R.; Chan H.W.; Wenz M.; Northrop J.P.; Ringold G.M.; Danielsen M.; Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci  1987,84(21),7413-7417","journal-title":"Proc Natl Acad Sci"},{"key":"ref=94","first-page":"6831","volume":"62","author":"Campbell R.B.","year":"2002","unstructured":"Campbell R.B.; Fukumura D.; Brown E.B.; Mazzola L.M.; Izumi Y.; Jain R.K.; Torchilin V.P.; Munn L.L.; Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res  2002,62(23),6831-6836","journal-title":"Cancer Res"},{"key":"ref=95","first-page":"6132","volume":"62","author":"Ran S.","year":"2002","unstructured":"Ran S.; Downes A.; Thorpe P.E.; Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res  2002,62(21),6132-6140","journal-title":"Cancer Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"Lv H.","year":"2006","unstructured":"Lv H.; Zhang S.; Wang B.; Cui S.; Yan J.; Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release  2006,114(1),100-109","journal-title":"J Control Release"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/801820","volume":"2014","author":"Shrestha H.","year":"2014","unstructured":"Shrestha H.; Bala R.; Arora S.; Lipid-Based Drug Delivery Systems. J Pharm (Cairo)  2014,2014,1-10","journal-title":"J Pharm (Cairo)"},{"key":"ref=98","first-page":"47","volume":"100","author":"Maincent P.","year":"2007","unstructured":"Maincent P.; The regulatory environment: The challenges for lipid-based formulations. Bulletin Technique Gattefosse  2007,100,47-49","journal-title":"Bulletin Technique Gattefosse"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","volume":"60","author":"Chen M.L.","year":"2008","unstructured":"Chen M.L.; Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Adv Drug Deliv Rev  2008,60(6),768-777","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122117385268268231204061938","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226214\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122117385268268231204061938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:14:57Z","timestamp":1733465697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226214\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0122117385268268231204061938","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}